Delivery Order SPE2DB20D3104-SPE2DB25FV9H6
- Not listed
- The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $62,817.87 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5ml syringes. This competitively awarded, firm fixed-price delivery order is due for completion by September 29, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a $4,901.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes, with an ultimate completion date of August 1, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,633.77 delivery order contract to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevnar 20 syringes (0.5mL). This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The contract requires fulfillment by August 20, 2025, with performance at...
- The Defense Logistics Agency awarded a delivery order valued at $19,605.24 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive award under the company's existing contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,703.93 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 Syringe 0.5ML, a pneumococcal vaccine product. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded on August 8, 2025, with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $46,889.08 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. This firm fixed price contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,989.90 by the Defense Logistics Agency (DLA) on July 14, 2025. The order is for Prevnar 20 vaccine in 0.5ml syringes and will be completed by July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $8,078.82 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe format (0.5ML) with a firm fixed price and an ultimate completion date of July 11, 2025. This is a competitive, non-set-aside award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The award represents a child delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9H6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,633.77 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 Syringe 0.5mL, a pneumococcal vaccine, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major pharmaceutical distribution hub. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines, specialty medications, and related medical commodities. AmerisourceBergen's significant federal pharmaceutical procurement portfolio and demonstrated capability to fulfill Defense Health Agency and other government healthcare system requirements through competitive contract awards position the company as a critical vendor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/5/25 |